LB Pharmaceuticals Appoints Susan G. Kozauer, M.D. as Chief Medical Officer
Position
Chief Medical Officer
Company
LB Pharmaceuticals
New YorkHealthcareHealth CareDescription
On September 15, 2026, LB Pharmaceuticals Inc announced the appointment of Susan G. Kozauer, M.D. as the Chief Medical Officer, effective September 14, 2026
Quick answer
LB Pharmaceuticals Appoints Susan G. Kozauer, M.D. as Chief Medical Officer (September 15, 2026). LB Pharmaceuticals is based in New York, New York, United States.
- Who is the new Chief Medical Officer at LB Pharmaceuticals?
- LB Pharmaceuticals named Susan G. Kozauer, M.D. Chief Medical Officer, announced September 15, 2026.
- What did LB Pharmaceuticals announce on September 15, 2026?
- On September 15, 2026, LB Pharmaceuticals Inc announced the appointment of Susan G. Kozauer, M.D. as the Chief Medical Officer, effective September 14, 2026
- Where did Susan G. Kozauer, M.D. work before joining LB Pharmaceuticals?
- Susan G. Kozauer, M.D. joins from Centessa Pharmaceuticals.
- What does LB Pharmaceuticals do?
- LB Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of schizophrenia.
- Where is LB Pharmaceuticals based?
- LB Pharmaceuticals is based in New York, New York, United States.
- Which similar companies made leadership changes around the same time?
- Q32 Bio (September 14, 2026), TransMedics Group (September 10, 2026), Retension Pharmaceuticals (September 10, 2026) and Sparrow Pharmaceuticals (September 9, 2026) also announced leadership changes within 45 days of LB Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Health Care
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Q32 Bio Appoints José Trevejo as Chief Medical Officer and Ellie Hershberger as Chief Development Officer (September 14, 2026)
- TransMedics Appoints Fernando Araujo as Chief Financial Officer (September 10, 2026)
- Retension Pharmaceuticals Appoints LeAnne Bloedon as EVP of Clinical Development (September 10, 2026)
- Sparrow Pharmaceuticals Appoints George Eldridge as Chief Financial Officer (September 9, 2026)
- electroCore Appoints Joshua Lev and Michael Fox as Co-CEOs (September 9, 2026)
- CVRx Appoints John Landry as Chief Financial Officer (September 22, 2026)
Who to call at LB Pharmaceuticals, and when
A new leader at LB Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day LB Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at LB Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at LB Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment LB Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
LB Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.